Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 98

1.

Emerging drugs for psoriatic arthritis.

Caso F, Del Puente A, Peluso R, Caso P, Girolimetto N, Del Puente A, Scarpa R, Costa L.

Expert Opin Emerg Drugs. 2016 Jan 25. [Epub ahead of print]

PMID:
26807876
2.

Cardiovascular effects of Etanercept in patients with psoriatic arthritis: evidence from the cardiovascular risk in rheumatic diseases database.

Di Minno MN, Iervolino S, Zincarelli C, Lupoli R, Ambrosino P, Pizzicato P, Di Minno A, Pappone N, Peluso R.

Expert Opin Drug Saf. 2015 Dec;14(12):1905-13. doi: 10.1517/14740338.2015.1111870. Epub 2015 Nov 30.

PMID:
26618553
3.

Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies.

Caso F, Costa L, Del Puente A, Di Minno MN, Lupoli G, Scarpa R, Peluso R.

Ther Adv Chronic Dis. 2015 Nov;6(6):328-38. doi: 10.1177/2040622315608647. Review.

4.

Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis.

Caso F, Lubrano E, Del Puente A, Caso P, Peluso R, Foglia F, Benigno C, Girolimetto N, Bottiglieri P, Scarpa R, Costa L.

Expert Rev Clin Immunol. 2015 Dec 9:1-17. [Epub ahead of print]

PMID:
26558483
5.

Clinical assessment of endothelial function in patients with rheumatoid arthritis: A meta-analysis of literature studies.

Di Minno MN, Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, Tremoli E.

Eur J Intern Med. 2015 Dec;26(10):835-42. doi: 10.1016/j.ejim.2015.10.016. Epub 2015 Nov 4.

PMID:
26547241
6.

Psoriatic Disease: Clinical Staging.

Scarpa R, Caso F, Costa L, Peluso R, Spanò A, Lubrano E, Del Puente A, Moll JM.

J Rheumatol Suppl. 2015 Nov;93:24-6. doi: 10.3899/jrheum.150629.

PMID:
26523050
7.

The impact of concomitant diffuse idiopathic skeletal hyperostosis on the achievement of minimal disease activity in subjects with psoriatic arthritis.

Pappone N, Di Minno MN, Iervolino S, Lupoli R, Mader R, Zincarelli C, Peluso R.

Rheumatol Int. 2015 Dec;35(12):2041-6. doi: 10.1007/s00296-015-3303-4. Epub 2015 Jun 6.

PMID:
26048625
8.

Cardiovascular risk markers in patients with psoriatic arthritis: A meta-analysis of literature studies.

Di Minno MN, Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, Tremoli E.

Ann Med. 2015 Jun;47(4):346-53. doi: 10.3109/07853890.2015.1031822. Epub 2015 May 8.

PMID:
25953378
9.

Ankylosing spondylitis and posture control: the role of visual input.

De Nunzio AM, Iervolino S, Zincarelli C, Di Gioia L, Rengo G, Multari V, Peluso R, Di Minno MN, Pappone N.

Biomed Res Int. 2015;2015:948674. doi: 10.1155/2015/948674. Epub 2015 Mar 3.

10.

Management of arthropathy in inflammatory bowel diseases.

Peluso R, Manguso F, Vitiello M, Iervolino S, Di Minno MN.

Ther Adv Chronic Dis. 2015 Mar;6(2):65-77. doi: 10.1177/2040622314563929. Review.

11.

Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies.

Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, Di Minno MN.

Thromb Haemost. 2015 May;113(5):916-30. doi: 10.1160/TH14-11-0921. Epub 2015 Feb 26.

PMID:
25716931
12.

Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection.

Caso F, Cantarini L, Morisco F, Del Puente A, Ramonda R, Fiocco U, Lubrano E, Peluso R, Caso P, Galeazzi M, Punzi L, Scarpa R, Costa L.

Expert Opin Biol Ther. 2015 May;15(5):641-50. doi: 10.1517/14712598.2015.1011616. Epub 2015 Feb 4. Review.

PMID:
25652590
13.

Markers of cardiovascular risk in patients with antiphospholipid syndrome: a meta-analysis of literature studies.

Ambrosino P, Lupoli R, Di Minno A, Iervolino S, Peluso R, Di Minno MN.

Ann Med. 2014 Dec;46(8):693-702. doi: 10.3109/07853890.2014.959559. Epub 2014 Oct 13. Review.

PMID:
25307359
14.

Biological therapies for spondyloarthritis.

Bruner V, Atteno M, Spanò A, Scarpa R, Peluso R.

Ther Adv Musculoskelet Dis. 2014 Jun;6(3):92-101. doi: 10.1177/1759720X14535512. Review.

15.

Extra-articular manifestations in psoriatic arthritis patients.

Peluso R, Iervolino S, Vitiello M, Bruner V, Lupoli G, Di Minno MN.

Clin Rheumatol. 2015 Apr;34(4):745-53. doi: 10.1007/s10067-014-2652-9. Epub 2014 May 8.

PMID:
24803233
16.

Hemostatic and fibrinolytic changes are related to inflammatory conditions in patients with psoriatic arthritis--effect of different treatments.

Di Minno MN, Iervolino S, Peluso R, Di Minno A, Ambrosino P, Scarpa R; CaRRDs Study Group.

J Rheumatol. 2014 Apr;41(4):714-22. doi: 10.3899/jrheum.130850. Epub 2014 Feb 15.

PMID:
24532831
17.

Lipid profile changes in patients with rheumatic diseases receiving a treatment with TNF-α blockers: a meta-analysis of prospective studies.

Di Minno MN, Ambrosino P, Peluso R, Di Minno A, Lupoli R, Dentali F; CaRRDs Study Group.

Ann Med. 2014 Mar;46(2):73-83. doi: 10.3109/07853890.2013.874661. Epub 2014 Jan 27. Review.

PMID:
24460516
18.

Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers.

Di Minno MN, Peluso R, Iervolino S, Russolillo A, Lupoli R, Scarpa R; CaRRDs Study Group.

Ann Rheum Dis. 2014 Jun;73(6):1157-62. doi: 10.1136/annrheumdis-2012-202812. Epub 2013 Jun 14.

19.

Enteropathic spondyloarthritis: from diagnosis to treatment.

Peluso R, Di Minno MN, Iervolino S, Manguso F, Tramontano G, Ambrosino P, Esposito C, Scalera A, Castiglione F, Scarpa R.

Clin Dev Immunol. 2013;2013:631408. doi: 10.1155/2013/631408. Epub 2013 Apr 15. Review.

20.

Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies.

Peluso R, Cafaro G, Di Minno A, Iervolino S, Ambrosino P, Lupoli G, Di Minno MN.

Clin Rheumatol. 2013 Jun;32(6):743-53. doi: 10.1007/s10067-013-2252-0. Epub 2013 Apr 16. Review.

PMID:
23588881
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk